A comparative Study Of Oral 400 mg Natural Micronized Progesterone (OMP)Verses Vaginal 400 Mg Natural Micronized Progesterone (VMP) in Threatened Preterm Labour And Perinatal Neonatal Outcomes
DOI:
https://doi.org/10.52783/jns.v14.2707Keywords:
Preterm labour, oral micronized progesterone, vaginal micronized progesterone, neonatal morbidityAbstract
Preterm deliveries significantly contribute to neonatal mortalities and morbidities in children under the age of five. Progesterone, Tocolytics and steroid usage have been found to decrease the incidence of threatened preterm and neonatal mortality and morbidity. A prospective study was done to compare oral 400 mg natural micronized progesterone to vaginal 400 mg natural micronized progesterone and it was found that patients on OMP presented in labour earlier than patients on VMP i.e. the VMP group ended up in more term pregnancies.81.42% neonates of VMP were found to be asymptomatic as compared to smaller 72.85% neonates of OMP. Incidence of neonatal morbidity such as asphyxia was also found to be lesser in VMP as compared to OMP (10% vs 5.71%). NICU admission (4.28% vs 11.42%) was found higher in OMP group. Pertaining to the fact vaginal progesterone bypasses the first-pass metabolism, which explains its superior effectiveness in preventing preterm labour.
Downloads
Metrics
References
Walani SR. Global burden of preterm birth. Int J Gynaecol Obstet 2020; 150:31.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371:75.
Ohuma E, Moller A-B, Bradley E, et al. National, regional, and worldwide estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023;402(10409):1261-1271. doi:10.1016/S0140-6736(23)00878-4
Health Management Information System. (n.d.). www.hmis.mohfw.gov.in. https://hmis.mohfw.gov.in/#!/
Mostafa AH, Elaziz A. Oral Versus Vaginal Progesterone in PTL. Controlled Study. EBWHJ. 2017;7(4)141-149.
Deshpande H, Sharma MM, Reyaz A, et al. Assessment of efficacy of micronized progesterone by vaginal route for prevention of PTL. International Journal of Clinical Obstetrics and Gynaecology. 2019;3(6):294-298.
Srisutham K, Wuttikonsammakit P, Chamnan P. Efficacy of Vaginal and Oral Progesterone After Tocolytic Therapy in Threatened PTL: A 3-Arm Parallel- Group Randomized Controlled Trial. J Med Assoc Thai. 2021;104:746-756.
Boelig RC, Della Corte L, Ashoush S, et al. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2019;1(1):50-62
Dr. Alisha Das, Dr. Hemant G, Dr. Shristy Priya, Dr. Madhukar Shinde, Dr. CS Madkar. Comparative study of oral and vaginal natural micronized progesterone 300mg in preventing preterm labor in semi urban population. Int J Clin Obstet Gynaecol 2022;6(4):01-04. DOI: 10.33545/gynae.2022.v6.i4a.1185
Cheung KW, Seto MTY, Ng EHY. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial. Trials. 2020;21(1):121. Published 2020 Jan 30. doi:10.1186/s13063-020-4067-z
Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334:567–572. doi: 10.1056/NEJM199602293340904.
Fonseca EB, Celik E, Parra M, et al. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462–469. doi: 10.1056/NEJMoa067815.
DeFranco EA, O’Brien JM, Adair CD, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, doubleblind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30:697–705. doi: 10.1002/uog.5159.
da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–424. doi: 10.1067/mob.2003.41.
Simon JA, Robinson DE, Andrews MC, Hildebrand JR, Rocci ML, Blake RE, et al. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil Steril. 1993;60:26-33
Hemant G Deshpande, Chandrakant S Madkar, Madhukar J Shinde, et al. A Study Comparing Efficacy of Morning Dosage versus Evening Dosage of Oral Micronised Progesterone Sustained Release SR 300mg in Prevention of Preterm Labour. Indian J Obstet Gynecol. 2020;8(4):211–216.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
